SM
TENX icon

Sabby Management’s Tenax Therapeutics TENX Stock Holding History

Sabby Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21
Closed -$19K – 122
2020
Q1 		$19K Sell
21
-6
-22% -$10.5K 0.01% 82
2019
Q4 		$61K Buy
+27
New +$52.6K 0.02% 66
2019
Q1 		– Sell
-68
Closed -$131K – 124
2018
Q4 		$131K Buy
+68
New +$374K 0.03% 79
2017
Q2 		– Sell
-36
Closed -$300K – 258
2017
Q1 		$300K Sell
36
-11
-23% -$400K 0.02% 203
2016
Q4 		$2.96M Sell
47
-28
-37% -$1.64M 0.17% 77
2016
Q3 		$5.55M Sell
75
-6
-7% -$473K 0.21% 72
2016
Q2 		$6.67M Sell
81
-6
-7% -$501K 0.35% 47
2016
Q1 		$5.68M Buy
87
+3
+4% +$233K 0.28% 39
2015
Q4 		$8.84M Buy
84
+3
+4% +$311K 0.49% 36
2015
Q3 		$7.89M Sell
81
-3
-4% -$343K 0.33% 49
2015
Q2 		$9.91M Sell
84
-4
-5% -$456K 0.36% 60
2015
Q1 		$9.18M Buy
88
+15
+21% +$1.58M 0.38% 51
2014
Q4 		$9.03M Sell
73
-15
-17% -$1.82M 0.29% 42
2014
Q3 		$11M Buy
88
+3
+4% +$385K 0.42% 39
2014
Q2 		$11.1M Buy
85
+19
+29% +$2.93M 0.48% 36
2014
Q1 		$11.8M Buy
+66
New +$13.1M 0.66% 35
2013
Q4 		– Sell
-1
Closed -$54K – 242
2013
Q3 		$54K Buy
+1
New +$59K ﹤0.01% 188

Other funds holding TENX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sabby Management's TENX Position: Q2 2020 in Review

Sabby Management sold out of Tenax Therapeutics (TENX) in Q2 2020, closing a stake of 21 shares — an estimated $19K sold.

Sabby Management first reported a position in TENX in Q3 2013 and held it in 17 quarters. The position peaked at $11.8M in Q1 2014. 17 funds tracked by Wall St. Rank hold TENX as of Q2 2020.

  • Sabby Management reported no remaining Tenax Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Sabby Management sold 21 Tenax Therapeutics shares in Q2 2020, an estimated $19K.
  • Sabby Management first reported a position in Tenax Therapeutics in Q3 2013 and held it in 17 quarters.
  • Sabby Management's Tenax Therapeutics position peaked at $11.8M in Q1 2014.
  • 17 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2020.

Based on Sabby Management's 13F filing for Q2 2020, filed 14 Aug 2020.